RARX - Ra Pharmaceuticals Inc.
Previous close
47.995
0 0%
Share volume: 0
Last Updated: Wed 01 Apr 2020 06:00:00 AM CEST
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$48.00
0.00
0.00%
Summary score
45%
Profitability
50%
Dept financing
11%
Liquidity
75%
Performance
40%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.58%
Return on assets
-13.27%
Return on sales
0%
Return on invested capital
733.8%
Total debt ratio
9.46%
Debt ratio change over timeo
-1%
Current Ratio
15.06%
Quick Ratio
0%
Cash Position Ratio
15.67%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.27%
Return on assets
-10.92%
Return on sales
0%
Return on invested capital
2762.38%
Total debt ratio
6.91%
Debt ratio change over timeo
-0.99%
Current Ratio
18.98%
Quick Ratio
0%
Cash Position Ratio
18.46%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-14.03%
Return on assets
-13.31%
Return on sales
0%
Return on invested capital
403.21%
Total debt ratio
7.76%
Debt ratio change over time
-0.99%
Current Ratio
14.79%
Quick Ratio
0%
Cash Position Ratio
14.26%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-99.95%
Return on assets
-99.97%
Return on sales
0%
Return on invested capital
-49.52%
Total debt ratio
-100.12%
Debt ratio change over time
-1%
Current Ratio
-0.99%
Quick Ratio
0%
Cash Position Ratio
-0.71%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RARX | FTSV | PRNB | GCVRZ |
|---|---|---|---|---|
| Return on equity | -14.58% | -17.97% | -4.62% | 0% |
| Return on assets | -13.27% | -15.67% | -1.76% | 0% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | 733.8% | 161.19% | -572.22% | 0% |
| Profitability | 50% | 5% | 0% | 50% |
| Total debt ratio | 9.46% | 14.54% | 30.12% | 0% |
| Debt ratio change over time | -1% | -0.91% | -0.99% | 0% |
| Dept financing | 8% | 12% | 25% | 25% |
| Current Ratio | 18.98% | 8.83% | 14.71% | 0% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 18.46% | 3.13% | 2.25% | 0% |
| Liquididy | 75% | 17% | 22% | 0% |
| Short-term ratios | RARX | FTSV | PRNB | GCVRZ |
|---|---|---|---|---|
| Return on equity | -11.27% | -15.9% | -6.5% | 0% |
| Return on assets | -10.92% | -14.35% | -6.38% | 0% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | 2762.38% | 151.73% | -657.59% | 0% |
| Profitability | 50% | 1% | 0% | 50% |
| Total debt ratio | 6.91% | 13.9% | 10.19% | 0% |
| Debt ratio change over time | -0.99% | -0.91% | -0.99% | 0% |
| Dept financing | 12% | 25% | 18% | 25% |
| Current Ratio | 18.98% | 8.83% | 14.71% | 0% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 18.46% | 3.13% | 2.25% | 0% |
| Liquididy | 75% | 16% | 22% | 0% |